Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details
Active, Not Recruiting

Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis

NCT04074096

Conditions
BRAF V600 Mutation, Brain Diseases, Brain Metastases, +18 more
Locations
  • APHP - Hôpital Avicenne Bobigny, France
  • CHU de Bordeaux - Hôpital Saint André Bordeaux, France
  • GH Sud CHU Bordeaux - Hôpital Levêque Bordeaux, France
  • APHP - Hôpital Ambroise Paré Boulogne-Billancourt, France
View all 21 locations
View Trial Details
Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma

NCT05625399

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0125 Phoenix, Arizona, United States
  • Local Institution - 0189 Springdale, Arkansas, United States
  • Local Institution - 0098 Los Angeles, California, United States
  • Local Institution - 0093 Orange, California, United States
View all 149 locations
View Trial Details
Active, Not Recruiting

A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

NCT05912244

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Hartford Healthcare Alliance (Data Collection Only) Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Dinaciclib in Treating Patients With Stage IV Melanoma

NCT00937937

Conditions
Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma, +16 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
View all 190 locations
View Trial Details
Active, Not Recruiting

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT06131398

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Alliance for Multispecialty Research - Kansas City Merriam, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 25 locations
View Trial Details

Related conditions